• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒的体内动态及α干扰素治疗的抗病毒疗效。

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.

作者信息

Neumann A U, Lam N P, Dahari H, Gretch D R, Wiley T E, Layden T J, Perelson A S

机构信息

Department of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel.

出版信息

Science. 1998 Oct 2;282(5386):103-7. doi: 10.1126/science.282.5386.103.

DOI:10.1126/science.282.5386.103
PMID:9756471
Abstract

To better understand the dynamics of hepatitis C virus and the antiviral effect of interferon-alpha-2b (IFN), viral decline in 23 patients during therapy was analyzed with a mathematical model. The analysis indicates that the major initial effect of IFN is to block virion production or release, with blocking efficacies of 81, 95, and 96% for daily doses of 5, 10, and 15 million international units, respectively. The estimated virion half-life (t1/2) was, on average, 2.7 hours, with pretreatment production and clearance of 10(12) virions per day. The estimated infected cell death rate exhibited large interpatient variation (corresponding t1/2 = 1.7 to 70 days), was inversely correlated with baseline viral load, and was positively correlated with alanine aminotransferase levels. Fast death rates were predictive of virus being undetectable by polymerase chain reaction at 3 months. These findings show that infection with hepatitis C virus is highly dynamic and that early monitoring of viral load can help guide therapy.

摘要

为了更好地理解丙型肝炎病毒的动态变化以及α-2b干扰素(IFN)的抗病毒作用,利用数学模型分析了23例患者在治疗期间的病毒载量下降情况。分析表明,IFN的主要初始作用是阻断病毒粒子的产生或释放,每日剂量为500万、1000万和1500万国际单位时,阻断效率分别为81%、95%和96%。估计病毒粒子的半衰期(t1/2)平均为2.7小时,治疗前每天产生和清除10¹²个病毒粒子。估计的受感染细胞死亡率在患者之间存在很大差异(相应的t1/2 = 1.7至70天),与基线病毒载量呈负相关,与丙氨酸氨基转移酶水平呈正相关。快速死亡率预示着在3个月时通过聚合酶链反应无法检测到病毒。这些发现表明,丙型肝炎病毒感染具有高度动态性,早期监测病毒载量有助于指导治疗。

相似文献

1
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.丙型肝炎病毒的体内动态及α干扰素治疗的抗病毒疗效。
Science. 1998 Oct 2;282(5386):103-7. doi: 10.1126/science.282.5386.103.
2
Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy.标准治疗无应答者每日高剂量干扰素实现丙型肝炎病毒超快速清除
J Hepatol. 1998 Jun;28(6):960-4. doi: 10.1016/s0168-8278(98)80343-7.
3
The kinetics of hepatitis C virus infection.丙型肝炎病毒感染的动力学
Clin Liver Dis. 2001 Nov;5(4):917-30. doi: 10.1016/s1089-3261(05)70201-4.
4
Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.丙型肝炎病毒在体内的动态变化:利巴韦林和干扰素α对病毒周转的影响。
Hepatology. 1998 Jul;28(1):245-52. doi: 10.1002/hep.510280132.
5
Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo.干扰素α对丙型肝炎病毒体内周转动力学的影响。
Hepatology. 1996 Feb;23(2):366-71. doi: 10.1002/hep.510230225.
6
Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients.聚乙二醇干扰素-α-2b对HIV/HCV合并感染患者中HIV和HCV的差异抗病毒作用。
AIDS. 2007 Sep 12;21(14):1855-65. doi: 10.1097/QAD.0b013e32825eaba7.
7
Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.丙型肝炎病毒的24小时动力学及α干扰素的抗病毒作用
J Med Virol. 2006 Mar;78(3):365-71. doi: 10.1002/jmv.20548.
8
Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection.丙型肝炎病毒(HCV)与人类免疫缺陷病毒(HIV)合并感染患者在HCV治疗期间的病毒动态变化
J Infect Dis. 2003 Nov 15;188(10):1498-507. doi: 10.1086/379255. Epub 2003 Nov 13.
9
Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production.丙型肝炎病毒原发性感染的数学模型:非细胞溶解性清除及病毒体产生的早期阻断
Gastroenterology. 2005 Apr;128(4):1056-66. doi: 10.1053/j.gastro.2005.01.049.
10
Hepatitis C virus: kinetics and quasispecies evolution during anti-viral therapy.丙型肝炎病毒:抗病毒治疗期间的动力学和准种进化
Forum (Genova). 2000 Jan-Mar;10(1):32-42.

引用本文的文献

1
Within- and between-host evolutionary effects on viral oncogenicity.宿主内和宿主间进化对病毒致癌性的影响。
Virus Evol. 2025 Jun 6;11(1):veaf043. doi: 10.1093/ve/veaf043. eCollection 2025.
2
A multiscale model of the action of a capsid assembly modulator for the treatment of chronic hepatitis B.一种用于治疗慢性乙型肝炎的衣壳组装调节剂作用的多尺度模型。
PLoS Comput Biol. 2025 May 6;21(5):e1012322. doi: 10.1371/journal.pcbi.1012322. eCollection 2025 May.
3
Modeling challenges of hepatitis D virus kinetics during bulevirtide-based therapy.
基于布列韦肽治疗期间丁型肝炎病毒动力学的建模挑战
JHEP Rep. 2024 Sep 6;7(2):101211. doi: 10.1016/j.jhepr.2024.101211. eCollection 2025 Feb.
4
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-omicron or omicron variants: a modelling analysis of the randomized DisCoVeRy trial-authors' response.恩适得对感染前奥密克戎或奥密克戎变异株的COVID-19住院患者的抗病毒作用:随机发现试验的建模分析——作者回应
J Antimicrob Chemother. 2025 Mar 3;80(3):892-893. doi: 10.1093/jac/dkae447.
5
Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markers.联合血清替代标志物预测乙型肝炎患者cccDNA动态变化
PLoS Comput Biol. 2025 Jan 9;21(1):e1012615. doi: 10.1371/journal.pcbi.1012615. eCollection 2025 Jan.
6
The kinetics of SARS-CoV-2 infection based on a human challenge study.基于人体挑战研究的 SARS-CoV-2 感染动力学。
Proc Natl Acad Sci U S A. 2024 Nov 12;121(46):e2406303121. doi: 10.1073/pnas.2406303121. Epub 2024 Nov 7.
7
Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide.聚乙二醇干扰素对接受布列韦肽治疗的丁型肝炎病毒感染患者病毒动力学的影响。
JHEP Rep. 2024 Mar 24;6(8):101070. doi: 10.1016/j.jhepr.2024.101070. eCollection 2024 Aug.
8
A multiscale model of the action of a capsid assembly modulator for the treatment of chronic hepatitis B.一种用于治疗慢性乙型肝炎的衣壳组装调节剂作用的多尺度模型。
bioRxiv. 2024 Jul 16:2024.07.16.603658. doi: 10.1101/2024.07.16.603658.
9
Virus Quasispecies Rarefaction: Subsampling with or without Replacement?病毒准种稀疏化:有或无重复抽样?
Viruses. 2024 Apr 29;16(5):710. doi: 10.3390/v16050710.
10
Incorporating Intracellular Processes in Virus Dynamics Models.将细胞内过程纳入病毒动力学模型。
Microorganisms. 2024 Apr 30;12(5):900. doi: 10.3390/microorganisms12050900.